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A B S T R A C T
Mycobacteria, including most of all MTB (Mycobacterium tuberculosis), cause pathogenic infections
in humans and, during the infectious process, are exposed to a range of environmental insults,
including the host’s immune response. From the moment MTB is exhaled by infected individuals,
through an active and latent phase in the body of the new host, until the time they reach the
reactivation stage, MTB is exposed to many types of DNA-damaging agents. Like all cellular
organisms, MTB has efficient DNA repair systems, and these are believed to play essential
roles in mycobacterial pathogenesis. As different stages of infection have great variation in the
conditions in which mycobacteria reside, it is possible that different repair systems are essential
for progression to specific phases of infection. MTB possesses homologues of DNA repair
systems that are found widely in other species of bacteria, such as nucleotide excision repair,
base excision repair and repair by homologous recombination. MTB also possesses a system for
non-homologous end-joining of DNA breaks, which appears to be widespread in prokaryotes,
although its presence is sporadic within different species within a genus. However, MTB does not
possess homologues of the typical mismatch repair system that is found in most bacteria. Recent
studies have demonstrated that DNA repair genes are expressed differentially at each stage of
infection. In the present review, we focus on different DNA repair systems from mycobacteria and
identify questions that remain in our understanding of how these systems have an impact upon
the infection processes of these important pathogens.
INTRODUCTION
MTB (Mycobacterium tuberculosis), the causative agent
of TB (tuberculosis), is a micro-organism that is among
the greatest ‘enemies’ of humanity. According to a WHO
(World Health Organization) report from 2009 [1], more
than 2 billion people are currently infected with TB
bacilli and 1 in 10 of infected people will become sick
with active TB during their lifetime. Indeed, in 2008,
1.8 million of people died from TB [1]. Even though
several anti-mycobacterial drugs have been discovered
and are currently in use, the results of the applied
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chemotherapy are far from satisfactory. Treatment
requires many months of taking several drugs and there
are many side effects. The drugs are, in some cases,
difficult to obtain and therapeutic regimes are difficult
to follow. When coupled with the nature of MTB’s
infectious process itself, this has resulted in widespread
emergence of drug-resistant and multidrug-resistant
strains of MTB. Therefore it is of great importance to
understand how MTB succeeds in infecting its host, as
such advances in knowledge will help the therapeutic
fight against this pathogen. Proteins involved in DNA
metabolism offer interesting possibilities as drug targets,
because many of them provide essential functions to
bacteria and, in many cases, are distinct from human
proteins at the biochemical and structural level.
The infectious process of MTB can be divided into
several stages [2]. Infection begins when bacteria are
exhaled by infected individuals and are transported in
aerosol droplets through the air. Small numbers of
bacteria are then inhaled by healthy individuals and settle
as a primary infection that inhabits macrophages. At this
point, depending on the efficiency of the host’s immune
response, bacteria may be eradicated from the host
organism. However, if the host’s response is insufficient,
macrophage-residing mycobacteria inhibit the fusion of
phagosomes and lysosomes and, following the primary
infection stage, may enter a stage of latency in the form
of a granuloma. Several types of cells are recruited to
the site of infection, including lymphocytes, monocytes
and neutrophils, and they cluster together to form a
closed environment where the mycobacteria may reside
for decades. MTB resides in a state of latency until the
moment when there is the breakage of the granuloma and
reactivation of the disease (Figure 1). Important details
about each phase of the infection process will be discussed
below.
As mycobacteria are exposed constantly to hostile
environments, which, among other things, lead to lesions
and modifications of the bacterial DNA, the integrity
of its genome is protected by mechanisms of DNA
repair [3]. These mechanisms are important to consider
in the context of mycobacteria because they could
influence processes leading to drug resistance and they
may offer novel targets for antibiotics [4]. Mycobacteria
possess DNA repair systems common to prokaryotes,
such as HR (homologous recombination), BER (base
excision repair) and NER (nucleotide excision repair).
Mycobacteria also possess a system for NHEJ (non-
homologous end-joining) of DNA breaks, which is
widespread in prokaryotes, although its presence is
sporadic within different genera of bacteria. However,
in contrast with many other prokaryotes, mycobacteria
do not possess mechanisms known to be required for
MMR (mismatch repair) [5]. A description of the specific
roles of each protein involved in DNA repair exceeds
the space available within the present review; however,
Figure 1 Overview of the MTB infection process in humans
Infection of humans by MTB occurs via several distinct stages. At each stage of
infection, the bacteria are exposed to various types of stress that may induce
different types of DNA damage.
several recent reviews have covered mycobacterial DNA
repair proteins [4,6,7].
Microarray analysis has revealed that almost half
of the MTB DNA repair genes are continuously
expressed during exponential phase growth in broth,
suggesting that the bacteria have to continuously
counteract the constant exposure to DNA-damaging
agents [8] (see Supplementary Table S1 at http://
www.clinsci.org/cs/119/cs1190187add.htm). Intriguing-
ly, only a few of the genes associated with DNA repair are
required for optimal growth of MTB in broth, including
Rv2554c, dut, ligA, polA, adnB and those encoding the
NER-related proteins UvrD1, UvrD2 and UvrC [9] (see
Supplementary Table S1). In fact uvrD2 [10] and ligA
[11] have been shown to be essential for the survival
of Ms (M. smegmatis), a non-pathogenic saphrophytic
bacteria found mostly in soil, water or plants worldwide
and used as a genetic model for theMycobacterium genus.
Another MTB study identified that survival in vivo in
mice required three BER proteins (Ung, Nfo/End and
XthA), MazG and RecN [12]. Most of the MTB DNA
repair genes have been shown to be non-essential for
survival in broth, but the growth of a strain defective in
recA was slowed down [9] (see Supplementary Table S1).
Independent of the probable constitutive expression of
DNA repair genes, their expression changes in response
to different environments encountered during the process
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of infection. Thus, as we discuss below, in vitro and
in vivo studies provide us with an insight into the role
of DNA repair proteins in the pathogenesis of MTB at
different stages of infection. For more information see
Supplementary Table S1.
AEROSOL DROPLETS
MTB is transmitted in aerosol droplets, which are
coughed out by infected individuals. The size distribution
of the aerosol droplets is variable, but most particle
sizes are within the size that can be taken into the
respiratory system [13]. Experiments performed in 1969
reported that the rate of survival of mycobacteria in
aerosol droplets falls to 50 % after 6 h [14]. More recent
findings have shown that, if MTB is held for 5 min in an
aerosol of artificial saliva, its viability declines to 55 %,
after 30 min less than 10 % remain viable and after 1 h
the percentage of viable cells is close to zero [15]. The
authors of that study point out that the viability of
MTB might actually be further compromised because
of another factor influencing survival of mycobacteria
in the natural environment, namely UV radiation. In
fact UV radiation, apart from being present in the
natural environment, is a known agent for sterilizing
mycobacteria-contaminated air [16–18]. Environmental
studies highlight the importance of both factors in the
survival of mycobacteria; for example, lower transmission
rates of TB are observed at higher altitudes, where
humidity is low and the exposure to UV light is stronger
[19]. Studies based on artificially generated droplets
carrying BCG (M. bovis BCG), the causative agent of
TB in cattle, show a link between both factors: increased
UV resistance is observed at high relative humidity
[20]. Nevertheless, it is clear that the survival rate of
mycobacteria is drastically reduced when they remain
in the aerosol droplet, especially if it is exposed to
environmental conditions such as desiccation and UV
irradiation.
It is known that both desiccation and UV radiation
lead to DNA damage. Intracellular dehydration leads
to DSBs (double-strand breaks) of DNA, but also
DNA conformation changes and, as a result, a different
susceptibility to UV-induced DNA damage [21]. UV
exposure leads to cyclobutane pyrimidine dimers and
pyrimidine(6–4)pyrimidine photoproducts, in which two
adjacent pyrimidines are covalently linked. It also leads
to some damage of bases, producing cytosine hydrate
and thymine glycol. Thus it is clear that, in order to
survive the ‘outside host’ environmental stage of their life
cycle, mycobacteria must employ DNA repair systems.
However, currently it remains uncertain whether DNA
repair is active while the mycobacteria are still suspended
in aerosol droplets or when they inhabit their new host.
Desiccation of mycobacteria leads to DSBs in their
DNA and, if unrepaired, these can be lethal to the cells in
which they occur. There are two systems in mycobacteria
known to repair this kind of DNA damage: HR and
NHEJ. Construction of mutant strains of Ms lacking the
proteins RecA (for HR) and Ku and/or LigD (for NHEJ)
showed that neither system of DSB repair is essential
for growth in vitro [11]. However, both systems are
required to maintain the viability of Ms under desiccation
in the broth culture (Table 1) and, interestingly, the
susceptibility to desiccation of the mutant lacking both
HR and NHEJ did not vary from the susceptibility of
strains that were defective for only NHEJ or HR [22].
Whether such an outcome is a result of an interplay
between NHEJ and HR while repairing DSBs, or the
susceptibility of the RecA mutant is due to the disruption
of other cellular pathways, such as the SOS response, is
still unknown. Notably, differences in the environmental
niches of Ms and MTB must be taken into consideration
when assessing these data.
The core mechanism for removal and repair of UV-
induced damage is NER. It consists of the UvrABC
nuclease enzyme complex and the UvrD helicase.
Mutations that influence NER, including polA of Ms
[23], uvrB for both Ms [24] and MTB [25] and uvrD1 of
Ms [26], lead to increased susceptibility to UV radiation
in vitro (Table 1). Interestingly, the combined deletion
of both uvrB and uvrD1 of Ms has an additive effect
on the survival rate of mycobacteria under UV radiation
[26]. Such a result implies an involvement for both gene
products in NER, but also suggests that one of the
proteins has an additional role in another DNA repair
pathway. Which other repair systems could be involved
in UV damage repair? During broth growth, UvrD1 has
been reported to be an interaction partner for Ku protein,
one of the major proteins in NHEJ. Nevertheless, UvrD1
function in UV damage repair seems to be independent
of Ku, as a Ku-deficient strain of Ms displays wild-type
sensitivity to UV radiation [27,28].
Another type of DNA metabolism that is important
for the repair of UV-induced damage in vitro is HR.
MTB RecA is induced in Ms broth culture following
UV exposure [29], and mutation in recA makes this Ms
mutant increasingly susceptible to UV irradiation [26,30].
However, neither the effect of a double mutation in NER
and HR under UV-induced stress nor the relationship
between HR and NER proteins in mycobacteria is
completely understood.
Microarray analysis of MTB genes induced under UV
treatment in broth cultures confirmed the role of HR and
NER in the repair of such damage. It also highlighted sev-
eral other possible proteins that could be involved in such
repair, including Ogt, Ada/AlkA, DinF, Lhr, DinX and
DnaE2 [31,32]. It has to be underlined, though, that two
independent studies did not produce fully consistent res-
ults [31,32] (see Table 1). Another puzzling observation
C© The Authors Journal compilation C© 2010 Biochemical Society
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Table 1 DNA repair genes affected by UV or desiccation
All results are for MTB unless otherwise stated, and are from in vitro studies, rather than aerosol droplet studies. +, Sensitivity or overexpression; *, at least a 2-fold
change in expression level.
Locus Gene Induced by UV in MTB [31]* Induced by UV in MTB [32] Mutants sensitive to UV exposure Mutants sensitive to desiccation in Ms [22]
Rv0937c ku +
Rv0938 ligD +
Rv0949 uvrD1 Ms + [26]
Rv1316c ogt +
Rv1317c ada, alkA +
Rv1629 polA Ms + [23]
Rv1633 uvrB + + [25]; Ms + [24]
Rv1638 uvrA +
Rv2593c ruvA +
Rv2594c ruvC + +
Rv2697c dut
Rv2719c +
Rv2720 lexA +
Rv2736c recX + +
Rv2737c recA + + Ms + [26,30] +
Rv3198c uvrD2 +
Rv3202c adnA +
Rv3296 lhr +
Rv3370c dnaE2 +
Rv3394c dinX +
Rv3395c dinF +
Rv3585 radA +
relates to the presence of MTB KatG catalase-peroxidase
with resistance to UV damage, since an Escherichia coli
recA-deficient strain carrying MTB katG had higher
survival rates under exposure to UV radiation in broth
culture [33]. The observed phenomenon was not due
simply to catalase-peroxidase activity. On the other hand
such an effect was not observed in tubercule bacilli clinical
strains [33]. However, katG is induced by UV radiation,
as identified in broth culture analysis of MTB [31].
MACROPHAGE INFECTION
The second stage of infection by mycobacteria starts as
soon as they are inhaled by a healthy individual. This
stage proceeds by the bacteria inhabiting and residing
in macrophages, eventually forming a granuloma. From
this point on the mycobacteria are continuously exposed
to both oxidative and nitrosative stress generated by the
activated macrophages that they inhabit [34].
Macrophages produce ROIs (reactive oxygen inter-
mediates) and RNIs (reactive nitrogen intermediates) as
cytotoxic agents in the immune response to pathogens.
Production of these compounds by host cells appears
to be essential in the control of mycobacterial infection,
as murine mutants deficient in NOS (NO synthase)
responsible for producing RNIs [34–36] or phagocyte
oxidase cytochrome b responsible for producing ROIs
[34] experience exaggerated mycobacterial infection. The
mutagenic effect and cytotoxic effect of ROIs and RNIs
is based on several chemical reactions leading to DNA
damage. NO can undergo auto-oxidation to form N2O3
(nitrous anhydrate), which can nitrosinate amines to
N-nitrosamines, which, after activation, alkylate DNA
through an indirect mechanism [37]. Direct nitrosation
of DNA bases leads to the formation of diazonium
ions and subsequent deamination, which can result in
base transitions, transversions and cross-links. Moreover,
deamination of guanine leads to the formation of
xanthine, which is unstable in DNA and can depurinate
easily, leaving an abasic site that can be cleaved by
endonucleases to generate single strand breaks. NO
can also react with superoxide giving rise to ONOO−
(peroxynitrite), a compound which causes more severe
DNA damage at smaller doses than NO. ONOO− can
nitrate DNA, resulting in the damage described above,
but it can also oxidize it [37]. Even though oxidation can
occur on all four bases of DNA, the most common DNA
lesion that is used as a marker of oxidative stress is the
formation of 8-hydroxyguanine [38]. Oxidized bases can
sometimes be pro-mutagenic and, since some can block
replication forks, they can be lethal [39].
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One of the first lines of defence against pathogens
invading the respiratory tract is the surfactant of the
lungs. Within the fluid, SPs (surfactant proteins) are
responsible for interacting with incoming pathogens. Of
particular interest, SP-A increases phagocytosis of BCG
[40] and, while in complex with BCG, has been shown to
stimulate expression of NOS by rat alveolar macrophages
[41]. However, contact with surfactant itself, without the
presence of macrophages, seems to have a minor effect
on the expression of DNA repair genes in MTB. Results
from a transcriptional analysis of the response of MTB to
bovine lung surfactant show that only one DNA repair
gene, mutY, was up-regulated upon contact with bovine
lung surfactant, whereas a few, including nth, Rv1160,
Rv0944 and ercc3, were down-regulated [42].
Several studies have confirmed the role of myco-
bacterial proteins involved in NER and BER in the
removal of damage encountered in macrophages (Table 2).
Interestingly, the MTB gene ada/alkA was up-regulated
in both human [43] and murine [44] macrophages and up-
regulated in response to H2O2 in broth culture [32,44].
Furthermore, MTB strains deficient in ada/alkA had
increased susceptibility to RNIs, but the gene seems
to be irrelevant for MTB during survival in mice, as
the knockout mutant had a wild-type survival rate
[45]. Further interesting observations have been made in
relation to uvrB, which is required for optimal growth of
MTB in mice [25]. Two studies showed, using different
reagents and methods, that Ms with uvrB knocked out
were more susceptible to ROIs than the wild-type in
broth culture [24,26]. However, experiments in MTB,
performed using a disc diffusion assay on agar plates [25]
and in broth cultures [45a] but performed with slight
modifications of the methods in relation to the studies
performed in Ms, produced contradictory results. The
differences in the results obtained in Ms and MTB may
be a result of the different approaches used by the authors;
however, deletion of uvrB in both MTB and Ms increased
their susceptibility to RNIs in broth cultures (Table 2).
Microarray experiments suggest that HR genes are
expressed during the active phase of infection (Table 2).
MTB genes involved in this type of repair were up-
regulated within murine macrophages or in response
to H2O2 [44] and also in human macrophages [46].
However, microarray experiments following phagocyt-
osis by human and murine macrophages suggest possible
differences between the macrophage environments of
the two species. The pattern of gene expression in
both studies was different, most notably seen in
the case of recX, as it was up-regulated in murine
macrophages [44,47], but down-regulated after 4 h of
human macrophage infection [43] (Table 2).
Studies have reported that expression of the NHEJ
major proteins is unaltered in response to the
environment encountered in macrophages. However,
since the core NHEJ proteins are constitutively expressed
in MTB during exponential growth in the broth culture
[8], NHEJ might still play an important role at this
stage of infection. Taken together, the combined results
suggest that DSBs occurring in mycobacteria at this stage
of infection might be preferentially repaired by HR.
However, it is notable that a recA-deficient mutant of
BCG does not influence the bacteria’s rate of survival in
vivo in a mouse model, even though it shows increased
susceptibility to DNA alkylating agents in vitro [48].
Thus there is still much to learn as to whether DSBs
within the mycobacterial genome influence the infection
of macrophages. For more information regarding the
DNA repair gene response during the active stage of
infection of MTB, see Table 2.
GRANULOMA
After the active phase of infection is over, mycobacteria
persist in the infected lung and settle in to cause a
chronic infection. Constant antigenic stimulation and
accumulation of T-cells leads to the formation of a
granuloma, which can maintain viable bacilli for decades.
The architecture and environment of granulomas
vary between different organisms [49]. The structure
of a human granuloma is characterized by a central
region of large CD68+ epitheloid cells, surrounded
by macrophages, T-lymphocytes (predominantly CD4+)
and multi-nucleate giant Langerhans cells. In mice there
is a co-location of CD4+ T-cells and macrophages, some
of which differentiate into epitheloid cells, but the giant
Langerhans cells are absent. In both organisms there
is the presence of B-lymphocyte aggregates, but their
spatial relationship with other immune cells is different.
Another distinctive feature of human granulomas is
caseous necrosis, which is also absent in the murine
version. This is a central acellular eosinophilic region
of granuloma formed as a result of cells undergoing
necrosis and/or apoptosis under intense cytokine and
direct cell–cell activation. The central region of the
granuloma does not contain blood vessels and becomes
hypoxic [49], a feature not observed in the murine
model [50]. Hypoxia then further increases the chances
for cells to undergo necrosis [49]. As the granuloma
becomes necrotic, it may either be resolved by fibrosis
and calcification or become liquefied, therefore leading
to dissemination of any pathogens contained within it.
Details about granuloma formation and deconstruction
have been reviewed previously [51].
There is still an ongoing discussion as to whether
MTBs undergo cell division when they are inside
granulomatous tissue [52,53]. Nevertheless, it seems that
MTBs have varying gene expression within granuloma.
An important aspect in terms of DNA repair is that
the environment of a granuloma is hypoxic and hypoxia
leads to DNA damage [54,55]. As identified by in vitro
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Table 2 Active phase of infection-affected genes
All results are for MTB, unless otherwise described. +/−, Mutant increasingly susceptible or up-regulated gene/mutant presenting wild-type susceptibility or down-regulated gene; *, at least a 1.8-fold change in expression level; †, for more data,
see reference. SCID, severe combined immunodeficiency; vs., versus.
Mutant analysis Expression analysis
Sensitive to Broth culture Murine Human
Alkylating agents Decreased survival Response to bovine
RNIs vs. wild-type ROIs vs. wild-type vs. wild-type rate in mice vs. H2O2 treated vs. surfactant or or its Whole-animal
Locus Gene in vitro in vitro in vitro wild-type untreated culture components [42]† Macrophages studies Macrophages
Rv0054 ssb + [32]
Rv0413 mutT3 + (BALB/C and SCID mice) [47] + [108]
Rv0631c recC + (only in SCID mice) [47] + [108]
Rv0861c ercc3 −
Rv0944, nei2
Rv0949 uvrD1 Ms + [26] Ms + [26]
Rv1020 mfd + [109] + (only in SCID mice) [47]
Rv1160 mutT2 −
Rv1210 tagA
Rv1259 udgB Ms + [110] + [43]
Rv1316c ogt + [45] − [45] + [32,44]*
Rv1317c ada, alkA + [45] − [45] + [32,44]* + [44]* + [43]
Rv1329c dinG + [109]
Rv1420 uvrC + [46]
Rv1629 polA Ms + [23] + (only in SCID mice) [47]
Rv1633 uvrB + [25], Ms + [24,26] − [25,115], Ms + [24,26] + [25] + [32]
Rv1638 uvrA + [32] + [113]
Rv2090 + [109], + [44]*
Rv2191 + [44]*
Rv2592c ruvB + (SCID mice and broth) [47]
Rv2593c ruvA − [43]
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Table 2 (Contd).
Mutant analysis Expression analysis
Sensitive to Broth culture Murine Human
Alkylating agents Decreased survival Response to bovine
RNIs vs. wild-type ROIs vs. wild type vs. wild-type rate in mice vs. H2O2 treated vs. surfactantor or its Whole-animal
Locus Gene in vitro in vitro in vitro wild-type untreated culture components [42]† Macrophages studies Macrophages
Rv2697c dut + [46]
Rv2719c + [44]* + [44]*
Rv2736c recX + [32,44]* + [44]* + (only in SCID mice) [47] −[43]
Rv2737c recA Ms − [26] Ms + [26] BCG + [48] BCG − [48] + [32,44]*
Rv2836c dinF + [109] + (BALB/C and SCID mice) [47]
Rv2922c smc + (only in SCID mice) [47]
Rv2924c mutM, fpg Ms − [24] Ms + [24,112]
Rv2973c recG + [44]*
Rv2976c ung Ms + [24,110,111] Ms + [24]
Rv3014c ligA + (only in BALB/C mice) [47]
Rv3202c adnA + [32,44]* + [44]*
Rv3296 lhr + [44]* + [44]*
Rv3394c dinX + [32]
Rv3585 radA + [32,44]* + [44]*
Rv3589 muTY Ms − [93] +
Rv3674c nth −
Rv3715c recR − [44]*
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broth culture studies, several DNA repair genes of MTB
are induced or repressed under hypoxic conditions [56–
59] (for detailed information, see Supplementary Table
S2 at http://www.clinsci.org/cs/119/cs1190187add.htm).
However, even though there is a general trend for
the down-regulation of DNA repair genes under such
conditions, gene expression in different experiments
differ greatly from one another. These results highlight
that gene expression of mycobacteria might depend not
only on their current conditions, but also on the way they
achieved such a state, meaning that the results obtained
by different methods might not be entirely comparable.
Another factor that influences the survival of myco-
bacteria in a granuloma is starvation. It has been shown
that the response to such an environment is very quick;
after 4 h of incubation in PBS several genes changed their
expression, including xseA, which was down-regulated,
and mutT2 (Rv1160), which was up-regulated [60].
In long-term cultures (104 days) depleted of nutrients,
several genes of MTB underwent changes in their
expression profiles [61]. Some genes were maintained
as being either up-regulated (nfo, ada/alkA, ogt and
Rv2554c) or down-regulated (recN, Rv0269c, Rv2191
and mpg) for the extended period of time; however, most
of the genes underwent several changes in their expression
profiles (Supplementary Table S2). It was postulated that
the change in expression profile at day 18 was a result
of the stringent response as carbon sources were utilized,
whereas at day 75 the population was progressing towards
cell division, but changes in the expression profiles of
DNA repair genes also occurred at other times [61].
Another factor that is probably encountered by
mycobacteria within a granuloma is NO and related
RNIs. Several lines of evidence suggest that NO is
released in the lungs of people chronically infected with
MTB (for more details, see [62]). Intriguingly, non-
toxic concentrations of NO inhibit aerobic respiration
and growth and, together with limited amounts of
oxygen, prepare bacilli for survival in dormancy [63]. No
DNA repair genes were up-regulated during exposure of
mycobacteria to non-toxic concentrations of NO. Thus
any influence of NO over DNA repair pathways in
granulomas remains to be established.
In vitro studies of Ms deficient in DNA repair
genes showed that ung- and uvrB-deficient mutants
had increased sensitivity to hypoxia in broth culture
[24]. Interestingly, comparison of mutant strains deficient
in NHEJ and HR revealed that DSBs, at least those
caused by ionizing radiation in the stationary phase, are
preferentially repaired by NHEJ [22,28]. By contrast, a
recA-deficient genotype of BCG did not affect growth
in broth culture after oxygen depletion nor did it
influence survival in BALB/C mice [48]. However, recA-
deleted BCG harvested in oxygen-depleted medium had
increased susceptibility to metronidazole, an antibiotic
effective only with anaerobic bacteria, suggesting that
recA might have a role in maintaining genome stability
at chronic stages of infection [48].
In vivo whole-genome studies bring additional
important data about the influence of DNA repair genes
during infection with MTB. Within artificial granulomas
of mice (hollow fibre model), uvrA and recF became
up-regulated [64]. In vivo studies in a rabbit model
did not confirm these results as the only DNA repair
gene that significantly changed its expression during
latency, reactivation and immune reconstitution was
Rv2191 [65]. Note that a hollow fibre applied by
Karakousis et al. [64] allows the formation of an artificial
granuloma carrying tubercle bacilli extracellularly, in
contrast with a natural granuloma, where MTB is
maintained within macrophages. Mice infected with a
low dose of aerosolized MTB developed a persistent
infection, which became chronic around days 45–60 of
infection [66]. The results indicated that mycobacteria
remained active, especially during the middle phase of
chronic TB. At 60 days post-infection, hupB and recO
were down-regulated and ung was up-regulated [66].
This expression profile was different from the profile
encountered at the active stage of infection (day 15). Thus,
while residing in granulomatous tissue, mycobacteria
undergo several changes in their gene expression profiles
(for more details see Table 3 and Supplementary
Table S2).
Reactivation of infection begins when granulomas fail,
and there are two main reasons for this phenomenon. One
is the failure of the essential formation and maintenance
of co-location signals from macrophages and T-cells,
despite the presence of other responses that suggest the
T-cells remain effective. The other reason relates to a
decline in the host’s immunity, which may result from the
genetic susceptibility of the host or from environmental
reasons, such as co-infection with HIV [51]. Little is
known about the role of mycobacterial DNA repair
genes in reactivation of infection; however, it seems
that at least some of them are important for ensuring
the survival of the bacteria. One such gene is uvrB,
as an Ms strain deleted for this gene is compromised
in its recovery from hypoxia in broth culture [24]. In
vivo studies of dexamethasone-treated BALB/C mice,
in which mice were undergoing immune suppression,
revealed that expression of MTB genes ogt, dinG and
recA were increased during reactivation [66]. Ung was
up-regulated in the same experiment; however, it was also
up-regulated in mice that were not undergoing immune
suppression, and therefore presenting chronic TB.
Genome-wide expression analysis of mycobacteria
from clinical human lung samples also confirmed the
expression of tubercle bacilli DNA repair genes [67] (for
more details, see Table 3 and Supplementary Table S2).
Interestingly, even though the gene expression profiles of
all isolates were similar, the profiles of up-regulated DNA
repair genes were different in granuloma, pericavity and
C© The Authors Journal compilation C© 2010 Biochemical Society
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Table 3 MTB DNA repair genes up-regulated in granulomas in vivo
All results are for MTB. +, Indicates an up-regulated gene; *, performed with artificial granulomas [MTB encapsulated in poly(vinylidene fluoride) hollow fibres
implanted into the subcutaneous space]; †, results are on the basis of the supplementary material provided with the article, for more information see [67]. vs.,
versus.
Mouse [66] Human [67]†
Mouse BALB/c mice at BALB/c vs. broth Rabbit Granuloma Pericavity/distant Pericavity/distant
Locus Gene [64]* 45 vs. 15 days at 60 days [65] vs. broth lung vs. granuloma lung vs. broth
Rv0003 recF +
Rv0937c ku +
Rv1638 uvrA +
Rv2090 + + +
Rv2191 +
Rv2593c ruvA +
Rv2836c dinF + +
Rv2976c ung +
Rv3201c adnB +
Rv3394c dinX +
distant lung tissue and only Rv2090 was up-regulated
in all three of these isolates. The observed differences
could be a result of differential physiology within the
cells, but also because the pericavity and distant lung are
exposed to air, leading to a heterogenous environment for
the mycobacterial samples.
MYCOBACTERIA, CHEMOTHERAPY AND
EVOLUTION
One current important aspect of research into the
pathogenesis of mycobacteria relates to the influence of
added chemicals. An environment containing selective
antibiotics promotes the occurrence of mutations in
the pathogen’s genome [68,69]. Consistent with these
findings is the occurrence of drug-resistant strains of
MTB, which have been divided into two main groups.
MDR (multi-drug resistant) strains are resistant to two
front line drugs, isoniazid and rifampicin, and these
strains have been estimated to cover 5.3 % of all new
cases of TB around the world [1]. XDR (extensively drug-
resistant) strains are resistant to isoniazid and rifampicin
plus one of the fluoriquinolones and at least one
second-line injectable drug (capreomycin, kanamycin
or amikacin). Even though it is still to be established
whether MTB possess plasmids [70,71] and if there is a
functional conjugational apparatus in MTB [72,73], up
to now all drug-resistance determinants are thought to be
chromosomally encoded and to be a result of spontaneous
nucleoid mutations [74] or gene inactivation by a mobile
genetic element [75]. Mutations are acquired mainly
by deletions, insertions or single nucleotide alterations
or SNPs (single nucleotide polymorphisms). Acquired
resistance towards anti-tubercular compounds has been
shown to occur in a single SNP in drug target genes,
including rpoB [76–78], katG [76,77,79,80] and various
others [81–86]. MTB harbours relatively little genetic
diversity [5,87–89], but findings have shown that diversity
between closely related strains may be greater than
anticipated and it may be biologically significant [74,90].
Importantly, a larger amount of SNP diversity has been
observed in XDR strains [91].
As in all organisms, DNA repair genes directly
influence the rates and types of mutation that occur in
mycobacteria. When they are functioning properly, these
systems help maintain mutation rates at a low level, but
in various circumstances they can increase the prevalence
of specific types of mutations. First, DNA repair systems
might not be efficient enough to repair large amounts
of DNA damage, which can therefore lead to mutations.
Secondly, some DNA damage repair systems, such as
NHEJ [28] or translesion synthesis by DnaE2 [32,92], are
error-prone and the repair pathway can lead directly to
mutated sequences. Finally, mutations to DNA damage
repair proteins can lead to an increase in the mutation
rate, as has been observed upon deletion of ung, uvrB,
uvrD, fpg and udgB in Ms and ada/alkA together
with ogt in MTB (Table 4 and Supplementary Table
S3 at http://www.clinsci.org/cs/119/cs1190187add.htm).
Furthermore, mutY [93] and mutT1 [94] mutations have
been observed in drug-resistant phenotypes. Analysis
of isoniazid-resistant strains has suggested that the
SNPs responsible for resistance had arisen independently
[82].
Certain genotypes of mycobacteria are particularly
prone to acquiring mutations that result in drug
resistance. SNPs seem to be a driving force for two
common drug-resistant lineages of MTB, W-Beijing and
Haarlem. Both of these strains are extremely fit for
C© The Authors Journal compilation C© 2010 Biochemical Society
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Table 4 Response of DNA repair genes to chemotherapy by first- and second-line drugs and the influence on mutation acquisition
All results are for MTB, unless otherwise stated. +/−, Indicates an up-regulated gene or an increased mutation rate in a deficient mutant/down-regulated gene; *, performed with artificial granulomas [MTB encapsulated in poly(vinylidene fluoride)
hollow fibres, implanted into the subcutaneous space]; †, at least a 2-fold change in expression level compared with untreated cultures.
Izoniazyd [106]
Izoniazyd Exponential Nutrient Progressive Capreomicine Rifampicin Streptomycin Amikacin Levofloxacin Ofloxacin Increased mutation
Locus Gene [103] phase growth Dormancy* depletion hypoxia [104] [31]† [31]† [31]† [31]† [31]† rate if absent
Rv0003 recF − −
Rv0054 ssb +
Rv0269c +
Rv0427c xthA +
Rv0630c recB − −
Rv0670 nfo, end + +
Rv0938 ligD +
Rv0944, nei2
Rv0949 uvrD1 Ms + [26]
Rv1021 mazG + −
Rv1210 tagA − +
Rv1259 udgB Ms + [110,114]
Rv1316c ogt + + [45]
Rv1317c ada, alkA + + + [45]
Rv1420 uvrC −
Rv1537 dinX + +
Rv1629 polA +
Rv1633 uvrB + Ms + [24,26]
Rv1638 uvrA +
Rv2191 +
Rv2592c ruvB −
Rv2594c ruvC −
Rv2697c dut
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Table 4 (Contd.)
Izoniazyd [106]
Izoniazyd Exponential Nutrient Progressive Capreomicine Rifampicin Streptomycin Amikacin Levofloxacin Ofloxacin Increased mutation
Locus Gene [103] phase growth Dormancy* depletion hypoxia [104] [31]† [31]† [31]† [31]† [31]† rate if absent
Rv2719c +
Rv2720 lexA +
Rv2737c recA +
Rv2924c mutM, fpg − Ms + [24,112]
Rv2973c recG −
Rv2976c Ung Ms + [24,110,111]
Rv2985 mutT1 +
Rv2986c hupB −
Rv3198c uvrD2
Rv3201c adnB +
Rv3202c adnA +
Rv3296 lhr +
Rv3297 nei
Rv3395c dinF +
Rv3585 radA +
Rv3674c nth −
Rv3715c recR − + +
Rv3731 ligC −
Rv3908 mutT4
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survival as they account for the majority of strains
identified in many countries [95–99] and both account for
a vast number of MDR and XDR strains [98–100]. It has
been discovered that many of these drug-resistant strains
carry mutations in DNA repair genes, resulting in their
mutator phenotype. ada/alkA, ogt [94,101] and ung [101]
mutations have been discovered in Haarlem lineages,
whereas mutT4, mutT2 and ogt have been discovered
in W-Beijing lineages [100,102]. The same mutations are
also observed in non-MDR strains, but this does not
negate the point that their mutator phenotype may in-
crease the possibility of them acquiring mutations against
anti-tubercular drugs.
Many anti-tubercular compounds influence the
expression of DNA repair genes in mycobacteria
[29,31,103–106] (Table 4 and Supplementary Table S3),
including first- and second-line drugs that are currently
used in therapy (Table 4). Although no DNA repair
genes were induced in response to the first-line drugs
pyrazinamide or ethambutol, under treatment with
ofloxacin, an inhibitor of DNA gyrase, ten of them were
up-regulated at least 2-fold [31]. It is, thus, a tempting
idea that the use of currently applied antibiotics combined
with drugs that target the up-regulated DNA repair genes
might increase the effectiveness of any chemotherapy.
In fact, a recA-deficient mutant of BCG had increased
susceptibility to metronidazole in vitro [48], and an ogt
mutant of BCG had increased susceptibility to isoniazid
[107]. However, it would be important to test such
strategies carefully to ensure that the reduction in the
activity of DNA repair proteins does not result in an
increased mutation rate that could contribute to the
generation of drug-resistant strains.
CONCLUSIONS
DNA repair pathways in mycobacteria are crucial for
their survival at different stages of infection. As infection
progresses, different sets of genes play an important role
in maintaining the stability of the mycobacterial genome.
Even though results obtained using different methods
are sometimes contradictory, an improved understanding
of the role of DNA repair in the pathogenesis of
mycobacteria might reveal good candidates for effective
treatment against tuberculosis. There is much data
regarding the expression of each DNA repair gene in
MTB; however, there is still a lot to discover and more
studies, especially performed in vivo with MTB, are
needed.
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